Orpea SA (ORPEF)
USD 14.22
(848.0%)
USD 14.22
(848.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.35 Billion EUR | 131.44% |
| 2022 | -4.3 Billion USD | -5916.93% |
| 2021 | 74.09 Million USD | -62.16% |
| 2020 | 195.82 Million USD | -25.44% |
| 2019 | 262.65 Million USD | 4.25% |
| 2018 | 251.93 Million USD | 133.67% |
| 2017 | 107.81 Million USD | -65.18% |
| 2016 | 309.6 Million USD | 125.06% |
| 2015 | 137.56 Million USD | -5.87% |
| 2014 | 146.14 Million USD | -6.89% |
| 2013 | 156.96 Million USD | 22.7% |
| 2012 | 127.92 Million USD | 22.69% |
| 2011 | 104.26 Million USD | 17.14% |
| 2010 | 89 Million USD | 1.47% |
| 2009 | 87.71 Million USD | 30.44% |
| 2008 | 67.24 Million USD | 11.54% |
| 2007 | 60.29 Million USD | 45.82% |
| 2006 | 41.34 Million USD | -8.02% |
| 2005 | 44.95 Million USD | 69.75% |
| 2004 | 26.48 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -276.34 Million USD | -114.51% |
| 2023 Q4 | 1.9 Billion USD | 571.01% |
| 2023 Q1 | -185.36 Million EUR | 95.07% |
| 2023 Q3 | 862.81 Million EUR | 332.73% |
| 2023 FY | 1.35 Billion EUR | 133.65% |
| 2023 Q2 | -404.37 Million USD | 89.94% |
| 2022 FY | -4.02 Billion EUR | -6277.87% |
| 2022 Q4 | -4.02 Billion USD | -1324.61% |
| 2022 Q3 | -1.87 Billion EUR | -597.5% |
| 2022 Q1 | -134.68 Million EUR | -262.33% |
| 2022 Q2 | -282.29 Million USD | -568.14% |
| 2021 Q4 | -42.25 Million USD | -134.81% |
| 2021 FY | 65.18 Million EUR | -59.27% |
| 2021 Q2 | 121.38 Million USD | 13.99% |
| 2021 Q3 | -18.58 Million EUR | -118.16% |
| 2021 Q1 | 51.17 Million EUR | -41.19% |
| 2020 Q2 | 82.01 Million USD | -38.79% |
| 2020 FY | 160.04 Million EUR | -31.6% |
| 2020 Q1 | 36.5 Million EUR | -69.41% |
| 2020 Q4 | 106.48 Million USD | 29.84% |
| 2020 Q3 | 43.51 Million EUR | -40.41% |
| 2019 Q3 | 59.67 Million EUR | -47.94% |
| 2019 Q1 | 57.31 Million EUR | 1.61% |
| 2019 FY | 233.99 Million EUR | 6.17% |
| 2019 Q2 | 130.54 Million USD | 1.22% |
| 2019 Q4 | 133.97 Million USD | 2.63% |
| 2018 Q4 | 128.96 Million USD | 2.68% |
| 2018 Q3 | 56.4 Million EUR | 4.87% |
| 2018 Q2 | 125.59 Million USD | -20.49% |
| 2018 Q1 | 53.78 Million EUR | -18.22% |
| 2018 FY | 220.39 Million EUR | 145.45% |
| 2017 Q1 | -20.87 Million EUR | -119.15% |
| 2017 FY | 89.78 Million EUR | -69.41% |
| 2017 Q3 | 65.77 Million EUR | 415.03% |
| 2017 Q4 | 157.95 Million USD | 431.67% |
| 2017 Q2 | -47.62 Million USD | -124.96% |
| 2016 Q4 | 190.83 Million USD | 152.73% |
| 2016 FY | 293.53 Million EUR | 131.8% |
| 2016 Q2 | 75.51 Million EUR | 0.0% |
| 2016 Q3 | 109.01 Million EUR | 188.73% |
| 2016 Q1 | 37.75 Million EUR | 5.94% |
| 2015 Q3 | 35.63 Million EUR | 28.76% |
| 2015 Q4 | 35.63 Million EUR | 0.0% |
| 2015 FY | 126.63 Million EUR | 4.85% |
| 2015 Q1 | 27.67 Million EUR | -26.14% |
| 2015 Q2 | 27.67 Million EUR | 0.0% |
| 2014 Q1 | 22.91 Million EUR | -19.32% |
| 2014 FY | 120.77 Million EUR | 6.03% |
| 2014 Q4 | 37.47 Million EUR | 0.0% |
| 2014 Q3 | 37.47 Million EUR | 63.52% |
| 2014 Q2 | 22.91 Million EUR | 0.0% |
| 2013 Q2 | 28.55 Million EUR | 0.0% |
| 2013 Q4 | 28.4 Million EUR | 0.0% |
| 2013 FY | 113.91 Million EUR | 17.4% |
| 2013 Q1 | 28.55 Million EUR | 0.0% |
| 2013 Q3 | 28.4 Million EUR | -0.51% |
| 2012 FY | 97.02 Million EUR | 20.81% |
| 2011 FY | 80.31 Million EUR | 21.05% |
| 2010 FY | 66.34 Million EUR | 8.52% |
| 2009 FY | 61.13 Million EUR | 26.38% |
| 2008 FY | 48.37 Million EUR | 17.32% |
| 2007 FY | 41.23 Million EUR | 31.52% |
| 2006 FY | 31.35 Million EUR | -17.73% |
| 2005 FY | 38.11 Million EUR | 95.61% |
| 2004 FY | 19.48 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.73 Million USD | 12721.295% |
| Arem Pacific Corporation | -53.66 Thousand USD | 2524787.884% |
| Assisted 4 Living, Inc. | -118.27 Thousand USD | 1145669.149% |
| BioCorRx Inc. | -3.76 Million USD | 36068.418% |
| Bionik Laboratories Corp. | -4.94 Million USD | 27493.7% |
| Banyan Corp. | -5.48 Million USD | 24810.812% |
| Clearday, Inc. | -14.3 Million USD | 9569.598% |
| Dental Patient Care America, Inc. | 8974.00 USD | -15097949.922% |
| Quantum Medical Transport, Inc. | 222.84 USD | -608014170.328% |
| Empower Clinics Inc. | -2826.87 USD | 47929399.897% |
| First Choice Healthcare Solutions, Inc. | -8.17 Million USD | 16681.331% |
| Selectis Health, Inc. | -3.97 Million USD | 34219.999% |
| Ethema Health Corporation | 1.17 Million USD | -115053.846% |
| HealthLynked Corp. | -1.01 Million USD | 133956.45% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.78 Million USD | 48694.545% |
| JRSIS Health Care Corporation | -80.91 Thousand USD | 1674634.062% |
| Comjoyful International Company | -20.62 Thousand USD | 6568988.781% |
| Medical Facilities Corporation | 18.5 Million USD | -7222.591% |
| MedSmart Group Inc. | -76.23 Thousand USD | 1777273.1% |
| North America Frac Sand, Inc. | -798.47 Thousand USD | 169785.414% |
| Nova Leap Health Corp. | -1.05 Million USD | 128565.29% |
| Nexteligent Holdings, Inc. | -295.32 Thousand USD | 458880.805% |
| PAO Group, Inc. | 235.5 Thousand USD | -575209.119% |
| Primemd Inc. | 3.14 Million USD | -43046.627% |
| Raffles Medical Group Ltd | 68.31 Million USD | -1883.368% |
| Ryman Healthcare Limited | 2.85 Million USD | -47373.403% |
| Stem Cell Authority, Ltd. | -4233.00 USD | 32008108.505% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -3.96 Million USD | 34305.491% |
| Mycotopia Therapies, Inc. | -1.18 Million USD | 114791.026% |
| U.S. NeuroSurgical Holdings, Inc. | -816 Thousand USD | 166141.544% |
| Veltex Corporation | -1.06 Million USD | 127552.131% |
| World Financial Holding Group | -28.42 Thousand USD | 4766507.514% |
| Xcelerate Inc. | -2.75 Million USD | 49356.517% |